Differences in kinetics of tacrolimus concentration after letermovir discontinuation by type of concomitant azole antifungal

[1]  H. Hashimoto,et al.  Drug interaction between letermovir and voriconazole after allogeneic hematopoietic cell transplantation , 2021, International Journal of Hematology.

[2]  J. McCrea,et al.  Assessment of Pharmacokinetic Interaction Between Letermovir and Fluconazole in Healthy Participants , 2020, Clinical pharmacology in drug development.

[3]  K. Ikegame,et al.  Tacrolimus Concentration after Letermovir Initiation in Hematopoietic Stem Cell Transplantation Recipients Receiving Voriconazole: A Retrospective, Observational Study , 2020, International journal of medical sciences.

[4]  W. Kraft,et al.  Pharmacokinetic Drug‐Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil , 2019, Journal of clinical pharmacology.

[5]  Karsten Menzel,et al.  PBPK Modeling Strategy for Predicting Complex Drug Interactions of Letermovir as a Perpetrator in Support of Product Labeling , 2018, Clinical pharmacology and therapeutics.

[6]  H. Stobernack,et al.  Pharmacokinetics and Safety of Letermovir Coadministered With Cyclosporine A or Tacrolimus in Healthy Subjects , 2018, Clinical pharmacology in drug development.

[7]  A. Groll,et al.  Drug‐drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4 , 2017, Transplant infectious disease : an official journal of the Transplantation Society.

[8]  Esther S. Kim,et al.  Letermovir: First Global Approval , 2017, Drugs.

[9]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[10]  Thomas M Polasek,et al.  Perpetrators of pharmacokinetic drug-drug interactions arising from altered cytochrome P450 activity: a criteria-based assessment. , 2011, British journal of clinical pharmacology.

[11]  M. Boeckh,et al.  How we treat cytomegalovirus in hematopoietic cell transplant recipients. , 2009, Blood.

[12]  H. K. Cho,et al.  Influence of fluconazole on the pharmacokinetics of omeprazole in healthy volunteers. , 2002, Biopharmaceutics & drug disposition.